BioCryst Pharmaceuticals Inc (BCRX): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$298.14M
As of 2021-12-31
+115.0%
3-year compound annual growth
+66.9%
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $298.14M | +143.2% | 2024-02-27, Balance as of period end |
| 2020-12-31 | $122.61M | +145.2% | 2023-02-27, Balance as of period end |
| 2019-12-31 | $50.00M | +66.7% | 2020-03-13, Balance as of period end |
| 2018-12-31 | $30.00M | +30.4% | 2019-03-14, Balance as of period end |
| 2017-12-31 | $23.00M | 0.0% | 2018-03-12, Balance as of period end |
| 2016-12-31 | $23.00M | n/a | 2017-02-27, Balance as of period end |